Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics. The Company's technology platforms have broad applicability and its long-term goal is to apply its proprietary gene editing technologies to a broad range of human diseases. The initial applications of Poseida’s technologies will be in gene therapy and CAR-T product candidates for liver disorders and cancer, respectively.